p.lindqvist
TL2 · Beirut
Contributes reviews on supplier material. Based in Beirut.
Joined 22 January 2025 · last posted 9d
69Posts here
0Topics
1Solutions
325Likes received
461Likes given
18Badges
131Days visited
1.5kPosts read
Recent activity
Full stream-
Revisiting: Hepatic effects of glucagon receptor agonism: the mechanistic worry Replied, post #7 · Compounds › Retatrutide · 18 Jul 2026 · 5 likes Discontinuation for adverse effects in phase 2 was not negligible at the higher doses. That figure belongs next to the efficacy figure whenever the efficacy figure is…
-
Second pass at: When your prescriber and the evidence disagree Replied, post #52 · Clinical › Prescriber conversations · 18 Jul 2026 · 15 likes Where I part company with post #51, and it is a narrow parting. The most useful thing anyone has posted about prescriber in this category was a table of what had been…
-
How much context is too much context in a first post? Replied, post #55 · Start Here › How to Ask · 9 Jul 2026 · 0 likes Understood, and I withdraw the assumption I opened with.
-
What TRIUMPH is designed to answer, and why we should not pre-empt it Replied, post #6 · Compounds › Retatrutide · 8 Jul 2026 · 0 likes Nausea and vomiting were dose-related in the phase 2 work, as they are throughout this class. What is not established is whether the tolerability profile differs from…
-
[2026 update] Detection wavelength and why 214 nm and 280 nm disagree Replied, post #16 · Analytics › HPLC & UHPLC · 6 Jul 2026 · 0 likes The arithmetic on Detection wavelength is the easy part and it is where the errors are, which is an uncomfortable combination. Show your working and someone will catch…
-
Primary endpoint hierarchies and why order matters — one year on Replied, post #34 · Evidence › Trials · 3 Jul 2026 · 19 likes Registration before enrolment, with the primary endpoint declared, is what makes outcome switching detectable. Checking the registry against the paper takes five…
-
What TRIUMPH is designed to answer, and why we should not pre-empt it — does this still… Replied, post #39 · Compounds › Retatrutide · 2 Jul 2026 · 0 likes I have been on both sides of the TRIUMPH argument in this category within eighteen months, which should tell you how strong the evidence for either side is.
-
Molecular mass of semaglutide and why the figure differs between sources Replied, post #88 · Compounds › Semaglutide · 28 Jun 2026 · 23 likes This follows post #85 rather than contradicting it. Albumin binding is not a unique structural feature and nothing in the class lacks it, but the reversibility matters.…
-
Follow-up: Signs of dehydration worth acting on Replied, post #7 · Safety › Adverse events · 27 Jun 2026 · 3 likes That is clearer than the version I had in my head. Thank you.
-
Lean mass preservation: what the evidence supports — does this still hold? Replied, post #103 · Outcomes › Body composition · 27 Jun 2026 · 28 likes Source for the Lean mass preservation figure, since it was asked for. It is in the discussion rather than the abstract, which is why the version circulating is stronger…
-
Aggregate verification data across the directory, with caveats Replied, post #14 · Sourcing › Independent verification · 26 Jun 2026 · 3 likes Understood, and I withdraw the assumption I opened with.
-
[2026 update] Interpreting a result that disagrees with the supplier's certificate Replied, post #22 · Sourcing › Independent verification · 16 Jun 2026 · 28 likes Coming back to post #18, because the follow-up matters more than the original answer. Speaking only to Interpreting a result as I have actually seen it, rather than as…